Photo by Simone van der Koelen on Unsplash
Photo by Advent Life Sciences

Mary Kerr


NeRRe Therapeutics




NeRRe Therapeutics








What makes Mary Kerr a Global Shaker?

Pharma is a notoriously male-dominated industry and women working in pharma often face significant barriers when it comes to reaching top positions.

UK-based Mary Kerr’s career is one to inspire all women that want to break into the industry.

Kerr has been CEO of NeRRe Therapeutics since CEO 2015. Before joining NeRRe Mary held a range of senior leadership roles in the pharmaceutical industry having spent the majority of her career on the R&D/commercial interface in global strategy and regional operational roles, predominantly in the specialty and orphan space.

She was a founding member of the executive team of ViiV Healthcare (the independent, HIV company that combines the HIV expertise of GSK, Pfizer Inc. and Shionogi) where she led, revitalised and grew the business throughout Europe.

Mary was also previously Senior Vice President and Global Franchise Head at GSK. Mary also currently leads KaNDy Therapeutics as CEO and is a non-executive independent director at Galapagos NV.

KaNDy is developing a potential breakthrough treatment for multiple symptoms of the menopause.

Mary gained a PhD in Pharmacology at the University of Bradford, did post-doctoral research at the Michigan Cancer Foundation, Detroit and has an MBA from the University of Kingston.

Tags: biotechnology, health, pharma, STEM

Last updated: November 8, 2019